Among them, the highest node degree target gene is EGF (upregulated in MS), which is an epidermal growth factor that binds to receptors on the cell membrane and activates the PI3K-Akt signaling pathway (63), and as mentioned earlier, inhibition of the “PI3K-Akt signaling pathway” is essential for MS treatment. This evidence concerns the gene EGF and myeloid sarcoma.